Several other studies demonstrated that aldosterone and MR signaling trigger podocyte damage through multiple mechanisms both in vitro and in vivo [100,101,102,103] and that MR blockade provides podocyte protection in CKD models [104,105]. The gene discussed is NR3C2; the disease is chronic kidney disease.